Johnson & Johnson (JNJ) Sale and Maturity of Investments (2009 - 2026)
Johnson & Johnson (JNJ) reported Sale and Maturity of Investments - Total of $308 million for Q3 2026, down 37.0% from $489 million a year earlier but up 93.7% from the prior quarter.
Powered by 
Analysis
Johnson & Johnson (JNJ) Sale and Maturity of Investments (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 27, 2026, Johnson & Johnson's Sale and Maturity of Investments - Total came in at $895 million, down 48.3% year-over-year; for FY2025, it came in at $1.66 billion, down 32.5% from FY2024.
- Sale and Maturity of Investments - Total has declined for three consecutive years, with a four-year compound annual growth rate of -39.2% (FY2021 to FY2025).
- By year, Sale and Maturity of Investments - Total came in at $2.46 billion in FY2024 (-87.3%), $19.39 billion in FY2023 (-53.4%), $41.61 billion in FY2022 and $12.14 billion in FY2021.
- Five-year quarterly Sale and Maturity of Investments - Total spans a low of $159 million in Q2 2026 and a high of $24.8 billion in Q4 2022.
- Year over year, Sale and Maturity of Investments - Total has now declined in each of the last four quarters, with an average decline of 38.5% over the last eight quarters.
- The high point for year-over-year Sale and Maturity of Investments - Total in five years was Q3 2025 (growth of 4.9%); the low point was Q4 2024 (a decline of 92.0%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $159 million (Q2 2026), $209 million (Q1 2026) and $219 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Investments Sold (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 308.00 Mn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | - |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 405.00 Mn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | 88.00 Mn |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | - |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 2.53 Bn |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn | 4.16 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 27, 2026 | 308.00 Mn |
| Jun 28, 2026 | 159.00 Mn |
| Mar 29, 2026 | 209.00 Mn |
| Dec 28, 2025 | 219.00 Mn |
| Sep 28, 2025 | 489.00 Mn |
| Jun 29, 2025 | 735.00 Mn |
| Mar 30, 2025 | 218.00 Mn |
| Dec 29, 2024 | 290.00 Mn |
| Sep 29, 2024 | 466.00 Mn |
| Jun 30, 2024 | 727.00 Mn |
| Mar 31, 2024 | 979.00 Mn |
| Dec 31, 2023 | 3.60 Bn |
| Oct 1, 2023 | 3.91 Bn |
| Jul 2, 2023 | 4.11 Bn |
| Apr 2, 2023 | 7.77 Bn |
| Jan 1, 2023 | 24.80 Bn |
| Apr 3, 2022 | 6.30 Bn |
| Oct 3, 2021 | 4.36 Bn |
| Jul 4, 2021 | 7.22 Bn |
| Apr 4, 2021 | 5.23 Bn |
API Access
Johnson & Johnson Sale and Maturity of Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=JNJ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "sale-and-maturity-of-investments", "ticker": "JNJ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=JNJ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();